Tag: EMA standards
Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Medications
Archives
Recent-posts
How the FDA Monitors Generic Drug Safety After Approval
Dec, 7 2025
Diacerein vs Alternatives: In‑Depth Comparison for Osteoarthritis
Oct, 25 2025
Actos: Everything You Need to Know About Pioglitazone for Type 2 Diabetes
Jun, 5 2025
Digestive Enzymes: When Supplements May Help GI Symptoms
Jan, 21 2026
How to Discuss Deprescribing Goals with Your Doctor: A Guide for Seniors
Jun, 18 2026